Side-by-side comparisons of Stock Rover and the research platforms investors most often weigh it against. Every page covers current pricing, a feature-by-feature table, and the cases where the other tool is the better choice.
Facts and pricing on all pages verified August 2026.
Koyfin is a polished market-data terminal: global macro coverage, elegant charts, earnings transcripts, with a capable free tier. Stock Rover goes deeper on fundamentals, screening, and dividend history, and includes brokerage-synced portfolio reporting that Koyfin reserves for its $79/mo tier. Fund research is the sharpest split: reports on 7,400 ETFs and 20,000 funds at $79/mo billed annually, versus Koyfin’s $209/mo Advisor plans.
Finviz owns the instant market overview: the fastest heat maps on the web and a free screener everyone knows. On annual billing the paid tiers land close together ($348 vs $299.50 a year), so the choice comes down to substance: 800+ screening metrics, 20-year fundamental history, and real portfolio tools against speed, breadth, and reach.
Seeking Alpha is analysis you read: thousands of contributor articles and quant ratings at $299/yr for Premium. Stock Rover is the numbers you verify it with: screening, 20-year fundamentals, and your own portfolio’s performance. Different jobs, and the page closes with the case for pairing them.
TIKR serves deep financials on 100,000+ global tickers with earnings transcripts, starting at $24.95/mo. Stock Rover matches the history depth on US equities and adds the layer TIKR doesn’t have: brokerage sync, portfolio performance reporting, and fund research without the $119.95/mo top tier.
Simply Wall St turns analysis into pictures, and its snowflake is the friendliest on-ramp in the category ($131.40–$258/yr). Stock Rover is the step up when the caps start to bind: report views are metered by tier and screeners top out at ten, versus unlimited research and 800+ metrics.
GuruFocus goes 30 years deep with every value metric ever devised, priced for it: $424 to $1,273 a year. Stock Rover Ultimate covers the working value-investor toolkit plus the portfolio layer at $948/yr. The page maps exactly where the extra archival depth is worth the difference.
TradingView has the best charting an individual can buy, from $14.95/mo, and this page says so plainly. Stock Rover wins the other side of the job: fundamentals, screening, fund research, and portfolio reporting. Many investors sensibly run both; the page shows where the line falls.
YCharts is built for advisors: 4,000+ metrics, an Excel add-in and client reporting, at a reported $3,600+ per seat per year. The page maps which of those an individual actually needs, and what Stock Rover covers from $348/yr.
Zacks Premium ($249/yr) sells the Zacks Rank and its long published record. Stock Rover sells the machinery for your own conclusions: 800+ metrics, 20-year data, portfolio reporting. The page shows where each pays for itself, and why some investors run both.
StockAnalysis.com is the best budget research site going: deep global fundamentals at $79/yr with a real free tier. The page is a fair fight about what the $269 difference buys: equation screening, brokerage sync, and a true performance report.
Sharesight keeps a meticulous dividend and corporate-action ledger across 60+ exchanges. For US investors the gaps matter: money-weighted returns only and limited US tax output. The page sorts out who each tracker actually fits.
Empower’s free dashboard is the best household money view in the US, and it stops exactly where investing decisions start: no screening, no dividend analytics, no research. The page covers what each does and why many people sensibly use both.
Snowball has the prettiest dividend dashboards in the category from $79.99/yr. Stock Rover adds what comes before the income: screening, 30-year payout history and safety context, plus performance reporting with stated methodology.
Six platforms compared by the reason you’d switch: cost, fund-data gating, portfolio features, or ease of use. Each entry lists current pricing and where it falls short, Stock Rover included.
What individual investors actually use a terminal for, and five consumer-priced tools that cover it: deep fundamentals, screening, portfolio analytics, and fund data, all under $1,300 a year.
Five upgrades matched to the wall you hit with Finviz: research depth, technical backtesting, visual analysis, or fund coverage. Pricing and weaknesses listed for every entry.
Six alternatives sorted by the reason you’d leave: you want data instead of opinions, ratings with a longer record, a cheaper read, or transcripts and markets coverage. Prices verified for every entry.
Our own review, structured the way an outside reviewer would write it: current pricing, what V12 added, real weaknesses, and a “who shouldn’t buy” section that names the better tool for four types of investor.
What dividend screening needs that generic screeners lack: 30-year payout histories, growth streaks, safety percentiles, and a 12-month income projection on your actual holdings. Five tools compared.
Fund research is the most price-gated corner of the market. This guide compares five tools on report depth, fee analytics in dollars, and portfolio look-through, with the gates and prices named.
Seven screeners compared on what separates a screener from a filter: metric depth, history, expressiveness, and what happens after the screen. Includes the best free screeners and a working screen-to-buy-list process.
Serious tracking means both return methodologies, dividends recorded and projected, risk vs a benchmark and fees in dollars. Five tools compared, including the free ones, with the pairings that actually work.
Every claim on these pages is testable in the 14-day trial, including the Portfolio Performance Report. No credit card required.
